Related Experiment Video
Updated: Feb 3, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
The Runx2 switch: unlocking osteoblast-related disorders through signaling pathways and non-coding RNAs
Somayeh Aslani1, Ashkan Kalantary-Charvadeh1, Roghayeh Abbasalipourkabir1
1Department of Clinical Biochemistry, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Abstract:
Osteoblasts, specialized bone-forming cells, differentiate from mesenchymal stem cells (MSCs). In recent years, stem cell-derived osteoblasts have emerged as potential choices for the treatment of bone-related disorders. A complex network of regulatory elements, including signaling pathways, transcription factors, and non-coding RNAs (ncRNAs), orchestrates MSCs differentiation. Among the key regulators of osteoblast differentiation is Runt-related transcription factor 2 (Runx2), a master transcription factor essential for osteogenic commitment. Elucidating the molecular mechanisms that regulate Runx2 expression and function is critical for the treatment of osteoblast-related disease. Runx2 is regulated through signaling pathways and a complex, post-transcriptional competing endogenous RNA (ceRNA) network. In this network, circular RNAs (circRNAs) and long non-coding RNAs (lncRNAs) sequester microRNAs (miRNAs), thereby fine-tuning Runx2 expression. Signaling pathways can also indirectly regulate Runx2 by inducing the expression of osteo-regulatory miRNAs. This review highlights the regulatory role of Runx2 during osteoblastic differentiation. It also explores how signaling pathways, lncRNAs, circRNAs, and other factors interact with Runx2-regulatory miRNAs involved in this process.
Insights
Runt-related transcription factor 2 (Runx2) is crucial for bone formation. This review explores how signaling pathways and non-coding RNAs regulate Runx2, offering insights into treating bone disorders.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Osteoblasts, derived from mesenchymal stem cells (MSCs), are vital for bone formation.
- Dysregulation of osteoblast differentiation contributes to bone-related disorders.
- Runt-related transcription factor 2 (Runx2) is a master regulator of osteoblast differentiation.
Purpose of the Study:
- To review the regulatory mechanisms governing Runx2 expression and function during osteoblast differentiation.
- To explore the interplay between signaling pathways, non-coding RNAs, and Runx2 in osteogenesis.
- To highlight the therapeutic potential of targeting these regulatory networks for bone disorders.
Main Methods:
- Literature review focusing on molecular mechanisms of osteoblast differentiation.
- Analysis of signaling pathways, transcription factors, and non-coding RNA networks.
- Integration of data on competing endogenous RNA (ceRNA) interactions involving Runx2.
Main Results:
- Runx2 expression and activity are tightly controlled by signaling pathways and a complex post-transcriptional ceRNA network.
- Long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) act as sponges for microRNAs (miRNAs), modulating Runx2 levels.
- Signaling pathways influence Runx2 indirectly by regulating osteo-regulatory miRNAs.
Conclusions:
- Runx2 is a central node in osteoblast differentiation, regulated by intricate molecular interactions.
- Understanding the ceRNA network and signaling pathways offers novel therapeutic strategies for bone diseases.
- Targeting Runx2-associated regulatory elements holds promise for regenerative medicine in bone repair.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
piRNA - Piwi-interacting RNAs
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

